3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Brain Neoplasms
10
Glioblastoma
5
Glioma
4
Disease
2
Recurrence
1
Neoplasms
1
Interventions
pembrolizumab
2
fluciclovine F-18
2
neratinib
1
alovudine
1
Temozolomide
1
Oncolytic Virotherapy
1
Magnetic Resonance Spectroscopy
1
Interleukin-15
1
Cyclophosphamide
1
Antibodies, Monoclonal
1
ABT-414
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Disease
×
fluciclovine F-18
×
CNS
×
Clear all
NCT04410133
2025-08-28
REVELATE
Blue Earth Diagnostics
Phase 3
Completed
151 enrolled
29 charts
NCT04410367
2025-07-20
PURSUE
Blue Earth Diagnostics
Phase 2
Completed
23 enrolled
10 charts